Kentucky medical scientist wins AHA Achievement Award for “extraordinary contributions” to cardiovascular research

Published on:

DALLAS, Nov. 18 – The American Heart Association has presented its Research Achievement Award for 2013 to Roberto Bolli, M.D., of the University of Louisville, “for the profound and lasting impact of his extraordinary contributions to cardiovascular research.”

“Over the past 40 years, Bolli has gained deserved recognition as a world leader in his field,” said American Heart Association president Mariell Jessup, M.D., of the University of Pennsylvania in presenting the award. “He has advanced our understanding of the mechanisms responsible for injury to the heart during ischemia and reperfusion, opening the way for developing novel protective strategies in patients with ischemic heart disease.”

Bolli is Professor of Medicine, Physics and Biophysics, Chief of the Division of Cardiovascular Medicine and Director of the Institute of Molecular Cardiology at the University of Louisville. He received the award, a citation and $2,500 honorarium, during the opening of the American Heart Association’s Scientific Sessions 2013 at the Dallas Convention Center.

In early studies Bolli established a primary role of oxygen-free radicals in development of reversible heart dysfunction, or “myocardial stunning.” His research further delineated at the molecular level how cardiac muscle adapts to stress, Jessup said.

More recently, Bolli has emerged as a leader in regenerative cardiology, the pioneering use of patient-derived cardiac stem cells to repair heart muscle damaged during a heart attack. The Kentucky scientist currently is directing the first major study to test the potential healing effect of patients’ own stem cells.

“Seamlessly melding basic experiments with patient-oriented studies has been a hallmark of Dr. Bolli’s research,” Jessup noted. “He has made great strides in solving the mysteries of ischemic heart disease and developing effective new approaches in the attack on this worldwide problem afflicting millions.”

 

Related Content

How TAVR valve choice impacts outcomes when treating type 1 bicuspid AS
Medtronic using AI to identify more TAVR patients in need
SAVR linked to higher 10-year survival rate than TAVR for low-risk patients
9 key takeaways from AHA 2024 in Chicago
Redo TAVR: The impact of implanting balloon-expandable valves in failed self-expanding valves
Edoxaban could limit blood clots, ‘make life easier’ for heart valve surgery patients

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."